PMC:7464116 / 50921-51097 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T550","span":{"begin":122,"end":130},"obj":"Disease"},{"id":"T551","span":{"begin":167,"end":170},"obj":"Disease"}],"attributes":[{"id":"A550","pred":"mondo_id","subj":"T550","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A551","pred":"mondo_id","subj":"T551","obj":"http://purl.obolibrary.org/obo/MONDO_0002492"}],"text":"Finally, they did not find that use of blockers of the Renin-Angiotensin and aldosterone system at hospital admission for COVID-19 disease was associated with greater AKI risk."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T90929","span":{"begin":61,"end":72},"obj":"Chemical"},{"id":"T66076","span":{"begin":77,"end":88},"obj":"Chemical"}],"attributes":[{"id":"A18486","pred":"chebi_id","subj":"T90929","obj":"http://purl.obolibrary.org/obo/CHEBI_2719"},{"id":"A23333","pred":"chebi_id","subj":"T66076","obj":"http://purl.obolibrary.org/obo/CHEBI_27584"},{"id":"A84741","pred":"chebi_id","subj":"T66076","obj":"http://purl.obolibrary.org/obo/CHEBI_30834"}],"text":"Finally, they did not find that use of blockers of the Renin-Angiotensin and aldosterone system at hospital admission for COVID-19 disease was associated with greater AKI risk."}

{"project":"LitCovid-sentences","denotations":[{"id":"T303","span":{"begin":0,"end":176},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Finally, they did not find that use of blockers of the Renin-Angiotensin and aldosterone system at hospital admission for COVID-19 disease was associated with greater AKI risk."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T228","span":{"begin":167,"end":170},"obj":"Phenotype"}],"attributes":[{"id":"A228","pred":"hp_id","subj":"T228","obj":"http://purl.obolibrary.org/obo/HP_0001919"}],"text":"Finally, they did not find that use of blockers of the Renin-Angiotensin and aldosterone system at hospital admission for COVID-19 disease was associated with greater AKI risk."}

{"project":"LitCovid-PubTator","denotations":[{"id":"1591","span":{"begin":77,"end":88},"obj":"Chemical"},{"id":"1615","span":{"begin":122,"end":130},"obj":"Disease"}],"attributes":[{"id":"A1591","pred":"tao:has_database_id","subj":"1591","obj":"MESH:D000450"},{"id":"A1615","pred":"tao:has_database_id","subj":"1615","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Finally, they did not find that use of blockers of the Renin-Angiotensin and aldosterone system at hospital admission for COVID-19 disease was associated with greater AKI risk."}